全球电子处方笺市场规模、份额、趋势和成长分析报告（2026-2034）

电子处方笺市场预计将从 2025 年的 61.2 亿美元成长到 2034 年的 533.8 亿美元，预计从 2026 年到 2034 年将以 27.21% 的复合年增长率成长。

随着医疗机构采用数位化解决方案来改善处方笺管理，全球电子处方笺市场正在快速成长。电子处方笺系统使医生能够创建处方笺并以电子方式发送给药房，从而减轻行政负担并最大限度地减少用药错误。这些系统有助于提高医疗运作效率并改善病患安全。

多种因素正在推动电子处方笺市场的成长。政府推行的数位化医疗系统和电子健康记录倡议，促进了电子处方笺解决方案的普及。此外，减少处方错误和改善药物追踪的需求日益增长，也进一步强化了对这些技术的需求。

随着医疗系统数位化的推进，电子处方笺市场预计将持续成长。与电子健康记录和药房管理系统的整合将进一步提升系统功能。随着医疗服务提供者致力于改善患者照护和提升营运效率，电子处方笺解决方案将继续发挥至关重要的作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球电子处方笺市场：依产品划分

• 市场分析、洞察与预测
• 解决方案（整合解决方案、独立解决方案）
• 服务（支援、实施、培训、网路）

第五章：全球电子处方笺市场：以交付方式划分

• 市场分析、洞察与预测
• 基于Web/云端
• 现场

第六章 全球电子处方笺市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 实践者
• 药局

第七章 全球电子处方笺市场：依使用方法划分

• 市场分析、洞察与预测
• 携带式的
• 基于计算机的设备

第八章：全球电子处方笺市场：依成分划分

• 市场分析、洞察与预测
• 管制物质
• 不受监管的物质

第九章：全球电子处方笺市场：依专科划分

• 市场分析、洞察与预测
• 肿瘤学
• 运动医学
• 神经病学
• 循环系统
• 其他的

第十章 全球电子处方笺市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十一章 竞争格局

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十二章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Cerner Corporation（Oracle）
  • Allscripts Healthcare LLC
  • Epic Systems Corporation
  • DrFirst
  • Athenahealth
  • NXGN Management LLC
  • McKesson Corporation
  • Surescripts
  • Change Healthcare
  • Practice Fusion Inc
  • Networking Technology Inc.（RXNT）

The E-Prescribing Market size is expected to reach USD 53.38 Billion in 2034 from USD 6.12 Billion (2025) growing at a CAGR of 27.21% during 2026-2034.

The global e-prescribing market has grown rapidly as healthcare providers adopt digital solutions to improve prescription management. E-prescribing systems allow physicians to generate and send prescriptions electronically to pharmacies, reducing paperwork and minimizing medication errors. These systems improve efficiency in healthcare operations and enhance patient safety.

Several factors are driving the growth of the e-prescribing market. Government initiatives promoting digital healthcare systems and electronic medical records are encouraging the adoption of electronic prescribing solutions. Additionally, the increasing need to reduce prescription errors and improve medication tracking has strengthened demand for these technologies.

Looking ahead, the e-prescribing market is expected to expand as healthcare systems continue to digitize medical processes. Integration with electronic health records and pharmacy management systems will enhance system functionality. As healthcare providers focus on improving patient care and operational efficiency, electronic prescribing solutions will remain essential tools.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Solutions (Integrated Solutions, Standalone Solutions)
• Services (Support, Implementation, Training, Network)

By Delivery Mode

• Web/Cloud-Based
• On-premise

By End-use

• Hospital
• Office-based Physicians
• Pharmacy

By Usage Methods

• Handheld
• Computer Based Devices

By Substances

• Controlled Substances
• Non-controlled Substances

By Specialties

• Oncology
• Sports Medicine
• Neurology
• Cardiology
• Others

COMPANIES PROFILED

• Cerner Corporation Oracle, Allscripts Healthcare LLC, Epic Systems Corporation, DrFirst, Athenahealth, NXGN Management LLC, McKesson Corporation, Surescripts, Change Healthcare, Practice Fusion Inc, Networking Technology Inc RXNT
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL E-PRESCRIBING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Solutions (Integrated Solutions, Standalone Solutions) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services (Support, Implementation, Training, Network) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL E-PRESCRIBING MARKET: BY DELIVERY MODE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Delivery Mode
• 5.2. Web/Cloud-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. On-premise Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL E-PRESCRIBING MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Office-based Physicians Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL E-PRESCRIBING MARKET: BY USAGE METHODS 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Usage Methods
• 7.2. Handheld Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Computer Based Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL E-PRESCRIBING MARKET: BY SUBSTANCES 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Substances
• 8.2. Controlled Substances Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Non-controlled Substances Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL E-PRESCRIBING MARKET: BY SPECIALTIES 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast Specialties
• 9.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Sports Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.5. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL E-PRESCRIBING MARKET: BY REGION 2022-2034(USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Product
  • 10.2.2 By Delivery Mode
  • 10.2.3 By End-use
  • 10.2.4 By Usage Methods
  • 10.2.5 By Substances
  • 10.2.6 By Specialties
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Product
  • 10.3.2 By Delivery Mode
  • 10.3.3 By End-use
  • 10.3.4 By Usage Methods
  • 10.3.5 By Substances
  • 10.3.6 By Specialties
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Product
  • 10.4.2 By Delivery Mode
  • 10.4.3 By End-use
  • 10.4.4 By Usage Methods
  • 10.4.5 By Substances
  • 10.4.6 By Specialties
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Product
  • 10.5.2 By Delivery Mode
  • 10.5.3 By End-use
  • 10.5.4 By Usage Methods
  • 10.5.5 By Substances
  • 10.5.6 By Specialties
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 South East Asia
  • 10.5.12 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Product
  • 10.6.2 By Delivery Mode
  • 10.6.3 By End-use
  • 10.6.4 By Usage Methods
  • 10.6.5 By Substances
  • 10.6.6 By Specialties
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL E-PRESCRIBING INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Cerner Corporation (Oracle)
  • 12.2.2 Allscripts Healthcare LLC
  • 12.2.3 Epic Systems Corporation
  • 12.2.4 DrFirst
  • 12.2.5 Athenahealth
  • 12.2.6 NXGN Management LLC
  • 12.2.7 McKesson Corporation
  • 12.2.8 Surescripts
  • 12.2.9 Change Healthcare
  • 12.2.10 Practice Fusion Inc
  • 12.2.11 Networking Technology Inc. (RXNT)